Diego A. Díaz García: cfDNA fragmentomics is redefining cancer detection
Mar 25, 2025, 20:07

Diego A. Díaz García: cfDNA fragmentomics is redefining cancer detection

Diego A. Díaz García, Medical Oncologist /CEO/Founder at CánCare – High Specialty in Oncology, shared on X:

“cfDNA fragmentomics is redefining cancer detection. Beyond mutations and methylation, genome-wide fragmentation patterns offer new biomarkers.

  • Reflects genomic and epigenomic states
  • Enhances early detection via AI-driven analysis”

Diego A. Díaz García